Spots Global Cancer Trial Database for adult mixed glioma
Every month we try and update this database with for adult mixed glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma | NCT00516282 | Brain and Centr... | CLORETAZINE temozolomide | 18 Years - | Northwestern University | |
| Everolimus in Treating Patients With Recurrent Low-Grade Glioma | NCT00823459 | Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult... | Everolimus Archival Tissue... | 18 Years - | University of California, San Francisco | |
| Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors | NCT00499798 | Brain and Centr... Chemotherapeuti... Infertility | 18 Years - 60 Years | Wake Forest University Health Sciences | ||
| Suramin in Treating Patients With Recurrent Primary Brain Tumors | NCT00002639 | Brain and Centr... | chemotherapy suramin | 15 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | NCT00002840 | Brain and Centr... | lomustine procarbazine hy... vincristine sul... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Everolimus in Treating Patients With Recurrent Low-Grade Glioma | NCT00823459 | Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult... | Everolimus Archival Tissue... | 18 Years - | University of California, San Francisco | |
| Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma | NCT00005951 | Brain and Centr... | irinotecan hydr... temozolomide | 18 Years - | Duke University | |
| Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00047294 | Brain and Centr... | celecoxib temozolomide thalidomide adjuvant therap... | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00047294 | Brain and Centr... | celecoxib temozolomide thalidomide adjuvant therap... | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma | NCT01103375 | Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... | erlotinib hydro... isotretinoin laboratory biom... protein express... | 18 Years - | Wake Forest University Health Sciences | |
| Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors | NCT00008086 | Brain and Centr... Unspecified Adu... | calcitriol carboplatin | 18 Years - | University of Pittsburgh | |
| Temozolomide in Treating Patients With Recurrent High-Grade Glioma | NCT00619112 | Recurrent Centr... | temozolomide | 18 Years - | University of California, San Francisco | |
| Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse | NCT00003775 | Brain and Centr... | leflunomide | 18 Years - | Pfizer | |
| Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma | NCT00036972 | Brain and Centr... | cintredekin bes... adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma | NCT00008008 | Brain and Centr... | filgrastim sargramostim cyclophosphamid... thiotepa autologous bone... bone marrow abl... peripheral bloo... | - | National Cancer Institute (NCI) | |
| Bevacizumab in Recurrent Grade II and III Glioma | NCT01164189 | Central Nervous... | Bevacizumab Temozolomide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy in Treating Patients With Malignant Glioma | NCT00612001 | Brain and Centr... | glioma-associat... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer | NCT00025558 | Brain and Centr... | filgrastim carboplatin temozolomide thiotepa autologous bone... peripheral bloo... | 1 Year - 49 Years | NYU Langone Health | |
| Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors | NCT00005083 | Brain and Centr... | conventional su... magnetic resona... magnetic resona... | 18 Years - 55 Years | Jonsson Comprehensive Cancer Center | |
| Everolimus in Treating Patients With Recurrent Low-Grade Glioma | NCT00823459 | Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult... | Everolimus Archival Tissue... | 18 Years - | University of California, San Francisco | |
| Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma | NCT00401024 | Brain and Centr... | imatinib mesyla... pharmacological... conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors | NCT00003731 | Brain and Centr... | temozolomide | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors | NCT00003461 | Brain and Centr... Metastatic Canc... Neuroblastoma | surgical proced... astatine At 211... | 18 Years - | Duke University | |
| ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma | NCT00352313 | Brain and Centr... | ATN-161 carboplatin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma | NCT00756106 | Brain and Centr... | temozolomide Imaging biomark... Photon Radiatio... | 18 Years - | Massachusetts General Hospital | |
| Fenretinide in Treating Patients With Recurrent Malignant Glioma | NCT00006080 | Brain and Centr... | fenretinide | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Melphalan With BBBD in Treating Patients With Brain Malignancies | NCT00253721 | Brain and Centr... Lymphoma Metastatic Canc... | Melphalan | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
| Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma | NCT00010049 | Brain and Centr... | imatinib mesyla... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor | NCT00070161 | Brain and Centr... Radiation Toxic... | EGb761 donepezil hydro... cognitive asses... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma | NCT00005082 | Brain and Centr... | biopsy magnetic resona... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Carmustine in Treating Patients With Recurrent Malignant Glioma | NCT00004028 | Brain and Centr... | carmustine conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas | NCT00002753 | Brain and Centr... | iodine I 131 mo... | 3 Years - | Duke University | |
| Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma | NCT00301873 | Brain Tumors Osteoporosis Central Nervous... | IV Zometa | 18 Years - | Duke University | |
| Biological Therapy in Treating Patients With Primary or Advanced Glioma | NCT00003067 | Brain and Centr... | aldesleukin lymphokine-acti... | 18 Years - | National Cancer Institute (NCI) | |
| Biological Therapy in Treating Patients With Primary or Advanced Glioma | NCT00003067 | Brain and Centr... | aldesleukin lymphokine-acti... | 18 Years - | National Cancer Institute (NCI) | |
| High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma | NCT01378481 | Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... | Vorinostat Stereotactic Ra... Laboratory Biom... Pharmacological... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas | NCT02175745 | Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Childhood High-... Childhood High-... Childhood Low-g... Childhood Low-g... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | 18F-fluoro-dihy... Positron emissi... Computed tomogr... Magnetic resona... | 16 Years - | Stanford University | |
| Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors | NCT00541138 | Brain and Centr... Metastatic Canc... Unspecified Adu... | carboplatin tamoxifen citra... topotecan hydro... pharmacological... | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer | NCT00025558 | Brain and Centr... | filgrastim carboplatin temozolomide thiotepa autologous bone... peripheral bloo... | 1 Year - 49 Years | NYU Langone Health | |
| Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases | NCT02967380 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult... | Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D... | 18 Years - | University of Southern California | |
| Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas | NCT00083096 | Brain and Centr... | lonafarnib temozolomide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors | NCT00003461 | Brain and Centr... Metastatic Canc... Neuroblastoma | surgical proced... astatine At 211... | 18 Years - | Duke University | |
| Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 | NCT01082926 | Anaplastic Astr... Anaplastic Epen... Anaplastic Meni... Anaplastic Olig... Brain Stem Glio... Ependymoblastom... Giant Cell Glio... Glioblastoma Gliosarcoma Grade III Menin... Meningeal Heman... Mixed Glioma Pineal Gland As... Brain Tumor | therapeutic all... aldesleukin laboratory biom... positron emissi... | 18 Years - 70 Years | City of Hope Medical Center | |
| Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma | NCT00058123 | Brain and Centr... | poly ICLC | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma | NCT00003467 | Brain and Centr... | carmustine polifeprosan 20... surgical proced... | 18 Years - | Duke University | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors | NCT00003478 | Brain and Centr... | conventional su... iodine I 131 mo... radiation thera... | 18 Years - | Duke University | |
| High Light and Low Light Dose PDT in Glioma | NCT00118222 | Brain and Centr... | porfimer sodium adjuvant therap... conventional su... | 18 Years - | Case Comprehensive Cancer Center | |
| Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma | NCT01635283 | Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... Adult Oligoastr... | tumor lysate-pu... laboratory biom... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma | NCT01095094 | Brain Tumor Anaplastic Astr... Anaplastic Epen... Anaplastic Olig... Brain Stem Glio... Giant Cell Glio... Glioblastoma Gliosarcoma Mixed Glioma | ritonavir lopinavir | 18 Years - | Case Comprehensive Cancer Center | |
| Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma | NCT00003467 | Brain and Centr... | carmustine polifeprosan 20... surgical proced... | 18 Years - | Duke University | |
| Bevacizumab in Recurrent Grade II and III Glioma | NCT01164189 | Central Nervous... | Bevacizumab Temozolomide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma | NCT00079092 | Brain and Centr... | procarbazine hy... thalidomide | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| High Light and Low Light Dose PDT in Glioma | NCT00118222 | Brain and Centr... | porfimer sodium adjuvant therap... conventional su... | 18 Years - | Case Comprehensive Cancer Center | |
| Fenretinide in Treating Patients With Recurrent Malignant Glioma | NCT00006080 | Brain and Centr... | fenretinide | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Topotecan in Treating Patients With Recurrent Brain Tumors | NCT00003372 | Brain and Centr... | topotecan hydro... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors | NCT00110032 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Grade III... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Supratent... Meningeal Melan... | EF5 conventional su... positron emissi... fluorine F 18 E... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Temozolomide in Treating Patients With Recurrent Malignant Glioma | NCT00004113 | Brain and Centr... | temozolomide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors | NCT00002754 | Brain and Centr... Melanoma (Skin) Metastatic Canc... | monoclonal anti... | 3 Years - | Duke University | |
| Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas | NCT01024907 | Adult Brain Tum... Adult Brain Ste... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Melanocyt... Adult Meningeal... Adult Mixed Gli... Adult Oligodend... Adult Pineal Gl... Adult Pineocyto... Recurrent Adult... | proton beam rad... quality-of-life... questionnaire a... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma | NCT01119599 | Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Primary M... Adult Subependy... Adult Subependy... Adult Supratent... Malignant Adult... | 3-Dimensional C... Gamma-Secretase... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Therapeutic Con... | 19 Years - | National Cancer Institute (NCI) | |
| Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma | NCT00112736 | Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult... | erlotinib temsirolimus therapeutic con... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases | NCT01234740 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Tumors Metastat... Adult Anaplasti... | bafetinib microdialysis pharmacological... liquid chromato... mass spectromet... laboratory biom... protein express... western blottin... immunohistochem... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Study of Tissue Samples From Patients With Glioma or Other Brain Tumors | NCT00967200 | Central Nervous... | laboratory biom... pharmacogenomic... | 18 Years - 120 Years | University Hospital, Montpellier | |
| Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma | NCT00005637 | Brain and Centr... | carmustine temozolomide | 18 Years - | National Cancer Institute (NCI) | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases | NCT01234740 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Tumors Metastat... Adult Anaplasti... | bafetinib microdialysis pharmacological... liquid chromato... mass spectromet... laboratory biom... protein express... western blottin... immunohistochem... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma | NCT00004892 | Brain and Centr... | O6-benzylguanin... polifeprosan 20... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme | NCT00892177 | Glioblastoma Mu... | bevacizumab dasatinib placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Sunitinib in Treating Patients With Recurrent Malignant Gliomas | NCT00499473 | Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pineal Gl... | sunitinib malat... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma | NCT00430079 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... | etanidazole conventional su... pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas | NCT00033280 | Brain and Centr... | temozolomide neoadjuvant the... radiation thera... | 18 Years - 65 Years | Radiation Therapy Oncology Group | |
| Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma | NCT00003467 | Brain and Centr... | carmustine polifeprosan 20... surgical proced... | 18 Years - | Duke University | |
| Suramin in Treating Patients With Recurrent Primary Brain Tumors | NCT00002639 | Brain and Centr... | chemotherapy suramin | 15 Years - | National Cancer Institute (NCI) | |
| Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma | NCT00027625 | Brain and Centr... | gefitinib temozolomide | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse | NCT00003775 | Brain and Centr... | leflunomide | 18 Years - | Pfizer | |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas | NCT01172964 | Adult Anaplasti... Recurrent Grade... Recurrent Grade... Adult Anaplasti... Adult Brain Tum... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Adult Anaplasti... Recurrent High ... | flucytosine polymerase chai... immunohistochem... gene therapy pharmacological... 3-Tesla magneti... laboratory biom... therapeutic con... E. coli CD-expr... | 13 Years - | City of Hope Medical Center | |
| Gene Therapy in Treating Patients With Recurrent Malignant Gliomas | NCT00004041 | Brain and Centr... | Ad5CMV-p53 gene conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| CC-5013 in Treating Patients With Recurrent Glioma | NCT00036894 | Brain and Centr... | lenalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases | NCT00276783 | Brain and Centr... Lymphoma Metastatic Canc... | pemetrexed | 18 Years - 120 Years | Northwestern University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
